QMS Medi Allied Ser.
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
QMS Medical Allied Services' board approved a composite scheme to demerge its Rs 37.17 crore healthcare services business into Saarathi Healthcare Private Limited along with the corresponding business of Health Care at Home India Private Limited. The scheme provided one Saarathi share for every QMS share held and envisaged a separate listing of Saarathi on the National Stock Exchange. The board also signed a binding memorandum to acquire 100% of BeamOptics Scientific Private Limited, a Pune-based maker of optics and diagnostic instruments with revenue of Rs 113.81 lakh in 2025-26. Saarathi became a wholly owned subsidiary on 17 September 2026 after QMS paid Rs 14.225 crore in cash for the final 24% stake. Saarathi reported turnover of Rs 18.45 crore in FY26. QMS reported consolidated revenue of Rs 172.88 crore in FY26 and Rs 56.9 crore in the first quarter of FY27. It migrated from NSE Emerge to the NSE Mainboard on 18 June 2026.
Powered by Tijori
QMS Medical Allied Services' board approved a composite scheme to demerge its Rs 37.17 crore healthcare services business into Saarathi Healthcare Private Limited along with the corresponding business of Health Care at Home India Private Limited. The scheme provided one Saarathi share for every QMS share held and envisaged a separate listing of Saarathi on the National Stock Exchange. The board also signed a binding memorandum to acquire 100% of BeamOptics Scientific Private Limited, a Pune-based maker of optics and diagnostic instruments with revenue of Rs 113.81 lakh in 2025-26. Saarathi became a wholly owned subsidiary on 17 September 2026 after QMS paid Rs 14.225 crore in cash for the final 24% stake. Saarathi reported turnover of Rs 18.45 crore in FY26. QMS reported consolidated revenue of Rs 172.88 crore in FY26 and Rs 56.9 crore in the first quarter of FY27. It migrated from NSE Emerge to the NSE Mainboard on 18 June 2026.
Powered by Tijori
QMS Medical Allied Services' board approved a composite scheme to demerge its healthcare services business, which reported turnover of Rs37.17 crore in the year to March, into Saarathi Healthcare Private Limited together with the equivalent business of Health Care at Home India Private Limited. The scheme provided one Saarathi share of Rs10 each for every QMS share held, and Saarathi was to seek a separate listing on the National Stock Exchange. Saarathi became a wholly owned subsidiary on 17 September after QMS paid Rs14.225 crore in cash for the final 24% stake, and recorded turnover of Rs18.45 crore in the year to March. QMS reported consolidated revenue of about Rs172.9 crore in the year to March, with sale of services at about 31% of the mix and rising to about 40% in the June quarter. The board also signed a binding memorandum to acquire all of BeamOptics Scientific, a Pune-based maker of optics and diagnostics instruments incorporated in October 2023 with turnover of about Rs1.14 crore in the year to March.
Powered by Tijori
QMS Medical Allied Services' board approved a composite scheme to demerge its healthcare services business, which reported turnover of Rs37.17 crore in the year to March, into Saarathi Healthcare Private Limited together with the equivalent business of Health Care at Home India Private Limited. The scheme provided one Saarathi share of Rs10 each for every QMS share held, and Saarathi was to seek a separate listing on the National Stock Exchange. Saarathi became a wholly owned subsidiary on 17 September after QMS paid Rs14.225 crore in cash for the final 24% stake, and recorded turnover of Rs18.45 crore in the year to March. QMS reported consolidated revenue of about Rs172.9 crore in the year to March, with sale of services at about 31% of the mix and rising to about 40% in the June quarter. The board also signed a binding memorandum to acquire all of BeamOptics Scientific, a Pune-based maker of optics and diagnostics instruments incorporated in October 2023 with turnover of about Rs1.14 crore in the year to March.
Powered by Tijori
QMS Medical Allied Services board approved a composite scheme of arrangement on 25 September to demerge its healthcare services business, together with that of Health Care at Home India, into Saarathi Healthcare. The undertaking transferred from QMS had turnover of Rs 37.17 crore in the year to March, or 24.41% of its turnover, and the scheme provided for one Saarathi share of Rs 10 for each QMS share held, with Saarathi seeking a listing on the National Stock Exchange. The board also approved a merger co-operation agreement and a shareholders agreement for Saarathi involving Conven Investment Holdings, Impact Assets, Windy Investments, Milky Investment and Trading, V I C Enterprises and promoter Mahesh Makhija. Separately, QMS signed a binding memorandum to acquire 100% of BeamOptics Scientific, a Pune maker of optics and diagnostic instruments incorporated in October 2023 with turnover of Rs 113.81 lakh in 2025-26, for consideration to be set by an independent valuer with completion indicated by 30 November 2027. Saarathi became a wholly owned subsidiary on 17 September after QMS paid Rs 14.225 crore in cash for the final 24% stake. Consolidated revenue was Rs 172.88 crore in the year to March, with services rising to about 40% of revenue in the June quarter on patient support programmes and screening camps.
Powered by Tijori
QMS Medical Allied Services board approved a composite scheme of arrangement on 25 September to demerge its healthcare services business, together with that of Health Care at Home India, into Saarathi Healthcare. The undertaking transferred from QMS had turnover of Rs 37.17 crore in the year to March, or 24.41% of its turnover, and the scheme provided for one Saarathi share of Rs 10 for each QMS share held, with Saarathi seeking a listing on the National Stock Exchange. The board also approved a merger co-operation agreement and a shareholders agreement for Saarathi involving Conven Investment Holdings, Impact Assets, Windy Investments, Milky Investment and Trading, V I C Enterprises and promoter Mahesh Makhija. Separately, QMS signed a binding memorandum to acquire 100% of BeamOptics Scientific, a Pune maker of optics and diagnostic instruments incorporated in October 2023 with turnover of Rs 113.81 lakh in 2025-26, for consideration to be set by an independent valuer with completion indicated by 30 November 2027. Saarathi became a wholly owned subsidiary on 17 September after QMS paid Rs 14.225 crore in cash for the final 24% stake. Consolidated revenue was Rs 172.88 crore in the year to March, with services rising to about 40% of revenue in the June quarter on patient support programmes and screening camps.
Powered by Tijori
QMS Medical Allied Services acquired an additional 24% stake in Saarathi Healthcare Private Limited for Rs14.23 crore in cash, lifting its holding to 100%, and Saarathi became a wholly owned subsidiary. Saarathi, which runs disease-management, early diagnosis and screening programmes using point-of-care devices and digital tools, posted turnover of Rs18.45 crore in the year to March 2026, up from Rs16.29 crore a year earlier and Rs13.33 crore the year before. QMS first took 51% of the Thane-based company in July 2024 and raised the holding to 76% during FY26. The group reported consolidated revenue of Rs172.88 crore in FY26, with services providing a growing share of the mix, and maintained a full-year revenue target of about Rs220 crore for FY27.
Powered by Tijori
QMS Medical Allied Services acquired an additional 24% stake in Saarathi Healthcare Private Limited for Rs14.23 crore in cash, lifting its holding to 100%, and Saarathi became a wholly owned subsidiary. Saarathi, which runs disease-management, early diagnosis and screening programmes using point-of-care devices and digital tools, posted turnover of Rs18.45 crore in the year to March 2026, up from Rs16.29 crore a year earlier and Rs13.33 crore the year before. QMS first took 51% of the Thane-based company in July 2024 and raised the holding to 76% during FY26. The group reported consolidated revenue of Rs172.88 crore in FY26, with services providing a growing share of the mix, and maintained a full-year revenue target of about Rs220 crore for FY27.
Powered by Tijori
Sept 17 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
BUYS ADDITIONAL 24% STAKE IN SAARATHI HEALTHCARE
COST OF ACQUISITION 142.3 MILLION RUPEES
Further company coverage: QMSM.NS
(([email protected];))
Sept 17 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
BUYS ADDITIONAL 24% STAKE IN SAARATHI HEALTHCARE
COST OF ACQUISITION 142.3 MILLION RUPEES
Further company coverage: QMSM.NS
(([email protected];))
QMS Medical Allied Services signed a five-year exclusive agreement with Germany-based HEINE Optotechnik to market and distribute its primary diagnostic instruments across India from 1 January 2027. HEINE's India net revenue was expected to be about €2.6 million, or roughly ₹30 crore, in 2026, while QMS expected turnover from the partnership to reach ₹70 crore by 2031. QMS reported consolidated total income of about ₹158 crore in FY25, when products accounted for roughly 71-72% of its reported mix. The company migrated from the SME platform to the NSE mainboard in June 2026.
Powered by Tijori
QMS Medical Allied Services signed a five-year exclusive agreement with Germany-based HEINE Optotechnik to market and distribute its primary diagnostic instruments across India from 1 January 2027. HEINE's India net revenue was expected to be about €2.6 million, or roughly ₹30 crore, in 2026, while QMS expected turnover from the partnership to reach ₹70 crore by 2031. QMS reported consolidated total income of about ₹158 crore in FY25, when products accounted for roughly 71-72% of its reported mix. The company migrated from the SME platform to the NSE mainboard in June 2026.
Powered by Tijori
June 12 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
QMS MEDICAL ALLIED SERVICES LTD - BECOMES HEALTHCARE VENDOR ON E-GRAMEEN PORTAL
Source text: ID:nNSE4256Gg
Further company coverage: QMSM.NS
(([email protected];))
June 12 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
QMS MEDICAL ALLIED SERVICES LTD - BECOMES HEALTHCARE VENDOR ON E-GRAMEEN PORTAL
Source text: ID:nNSE4256Gg
Further company coverage: QMSM.NS
(([email protected];))
Dec 2 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
QMS MEDICAL ALLIED SERVICES - APPROVED RAISING OF FUNDS UP TO 490 MILLION RUPEES
Source text: ID:nNSEb2fSqt
Further company coverage: QMSM.NS
(([email protected];))
Dec 2 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
QMS MEDICAL ALLIED SERVICES - APPROVED RAISING OF FUNDS UP TO 490 MILLION RUPEES
Source text: ID:nNSEb2fSqt
Further company coverage: QMSM.NS
(([email protected];))
Aug 29 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
TO RAISE FUNDS WORTH UP TO 490 MILLION RUPEES
Further company coverage: QMSM.NS
(([email protected];;))
Aug 29 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
TO RAISE FUNDS WORTH UP TO 490 MILLION RUPEES
Further company coverage: QMSM.NS
(([email protected];;))
June 6 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
QMS MEDICAL ALLIED SERVICES- DECIDED TO WITHDRAW APPLICATION PROPOSED FOR PREFERENTIAL ISSUE OF CONVERTIBLE SHARE WARRANTS, SHARES
Source text for Eikon: [ID:]
Further company coverage: QMSM.NS
(([email protected];))
June 6 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
QMS MEDICAL ALLIED SERVICES- DECIDED TO WITHDRAW APPLICATION PROPOSED FOR PREFERENTIAL ISSUE OF CONVERTIBLE SHARE WARRANTS, SHARES
Source text for Eikon: [ID:]
Further company coverage: QMSM.NS
(([email protected];))
April 19 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
QMS MEDICAL ALLIED SERVICES - OMRON HEALTHCARE INDIA JOINED HANDS WITH CO TO BOOST SALE OF MEDICAL DEVICES
Source text for Eikon: ID:nNSE9jMcWW
Further company coverage: QMSM.NS
(([email protected];))
April 19 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
QMS MEDICAL ALLIED SERVICES - OMRON HEALTHCARE INDIA JOINED HANDS WITH CO TO BOOST SALE OF MEDICAL DEVICES
Source text for Eikon: ID:nNSE9jMcWW
Further company coverage: QMSM.NS
(([email protected];))
Feb 26 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
QMS MEDICAL ALLIED SERVICES LTD - APPROVED ISSUE OF SHARE WARRANTS AND EQUITY SHARES ON PREFERENTIAL BASIS
Source text for Eikon: ID:nNSE7179Bt
Further company coverage: QMSM.NS
(([email protected];))
Feb 26 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
QMS MEDICAL ALLIED SERVICES LTD - APPROVED ISSUE OF SHARE WARRANTS AND EQUITY SHARES ON PREFERENTIAL BASIS
Source text for Eikon: ID:nNSE7179Bt
Further company coverage: QMSM.NS
(([email protected];))
Oct 30 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
TO ACQUIRE UPTO 8,25,000 SHARES AND CASH ASSETS OF SAARATHI HEALTHCARE
ACQUISITION BY SECONDARY MODE, IN ONE OR MORE TRANCHES FOR CASH CONSIDERATION OF 175.9 MILLION RUPEES
Further company coverage: QMSM.NS
(([email protected];))
Oct 30 (Reuters) - QMS Medical Allied Services Ltd QMSM.NS:
TO ACQUIRE UPTO 8,25,000 SHARES AND CASH ASSETS OF SAARATHI HEALTHCARE
ACQUISITION BY SECONDARY MODE, IN ONE OR MORE TRANCHES FOR CASH CONSIDERATION OF 175.9 MILLION RUPEES
Further company coverage: QMSM.NS
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does QMS Medi Allied Ser. do?
QMS Medical Allied Services Limited distributes a variety of medical devices, consumables, and its own branded products to clinics, pharmaceutical companies, and individual users. It includes medical consumables like disinfectants, filters, and wound management kits.
Who are the competitors of QMS Medi Allied Ser.?
QMS Medi Allied Ser. major competitors are Nureca, 3B Blackbio Dx, TTK Healthcare, Poly Medicure, Rajnish Wellness, Health X Platform, Max India. Market Cap of QMS Medi Allied Ser. is ₹378 Crs. While the median market cap of its peers are ₹915 Crs.
Is QMS Medi Allied Ser. financially stable compared to its competitors?
QMS Medi Allied Ser. seems to be less financially stable compared to its competitors. Altman Z score of QMS Medi Allied Ser. is 3.97 and is ranked 7 out of its 8 competitors.
Does QMS Medi Allied Ser. pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. QMS Medi Allied Ser. latest dividend payout ratio is 9.91% and 3yr average dividend payout ratio is 11.95%
How has QMS Medi Allied Ser. allocated its funds?
Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances
How strong is QMS Medi Allied Ser. balance sheet?
Balance sheet of QMS Medi Allied Ser. is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of QMS Medi Allied Ser. improving?
The profit is oscillating. The profit of QMS Medi Allied Ser. is ₹6.67 Crs for TTM, ₹9 Crs for Mar 2024 and ₹6.38 Crs for Mar 2023.
Is the debt of QMS Medi Allied Ser. increasing or decreasing?
Yes, The net debt of QMS Medi Allied Ser. is increasing. Latest net debt of QMS Medi Allied Ser. is ₹73.29 Crs as of Mar-26. This is greater than Mar-24 when it was ₹34.14 Crs.
Is QMS Medi Allied Ser. stock expensive?
Yes, QMS Medi Allied Ser. is expensive. Latest PE of QMS Medi Allied Ser. is 56.7, while 3 year average PE is 26.97. Also latest EV/EBITDA of QMS Medi Allied Ser. is 16.27 while 3yr average is 11.9.
Has the share price of QMS Medi Allied Ser. grown faster than its competition?
QMS Medi Allied Ser. has given better returns compared to its competitors. QMS Medi Allied Ser. has grown at ~6.07% over the last 3yrs while peers have grown at a median rate of -0.76%
Is the promoter bullish about QMS Medi Allied Ser.?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in QMS Medi Allied Ser. is 68.11% and last quarter promoter holding is 68.11%.
Are mutual funds buying/selling QMS Medi Allied Ser.?
There is Insufficient data to gauge this.